Last reviewed · How we verify
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer
The goal of this clinical trial is to investigate the efficacy, safety and tolerability of Ivonescimab combined with Cadonilimab and chemotherapy in extensive-stage small cell lung cancer patients. And also explore the potential biomarkers for predicting the efficacy of Ivonescimab combined with Cadonilimab for extensive-stage small cell lung cancer.
Details
| Lead sponsor | Shanghai Pulmonary Hospital, Shanghai, China |
|---|---|
| Phase | PHASE2 |
| Status | NOT_YET_RECRUITING |
| Enrolment | 70 |
| Start date | Mon Sep 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Thu Sep 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- SCLC, Extensive Stage
Interventions
- Arm 1
- second-line group